PYCR2 and hepatocellular carcinoma: Findings were independently validated, including primary HCC tissue and functional in vitro studies, confirming potentially actionable candidates during hepatocarcinogenesis (RRM2, GMPS, BCAT1, PYCR2, and NEU1) that might be useful for the design of personalized chemopreventive strategies in the future.